Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study
- PMID: 17177016
- DOI: 10.1007/s00787-006-1007-8
Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study
Erratum in
- Eur Child Adolesc Psychiatry. 2009 Mar;18(3):194-6
Abstract
Objectives: To provide psychometric information on the Attention-Deficit/Hyperactivity Disorder (ADHD) Rating Scale-IV (ADHD-RS-IV) in a large population of children with ADHD.
Methods: Patients aged 6-18 years (n=1,478 in baseline analysis) were rated by 244 physicians on the ADHD-RS-IV based on a semi-structured interview with the patient's parent. Physicians additionally rated functional impairment (CGAS) and health status (CGI-S), and parents rated their child's behavioural and emotional problems (SDQ) and quality of life (CHIP-CE).
Results: Inattention and hyperactivity-impulsivity as dimensions of ADHD were replicated. 3-factor solutions reflecting the ICD-10 definition, with hyperactivity, impulsivity and inattention as separate dimensions were extracted in some national sub-samples and in separate analyses for boys and younger children.Good internal consistencies, strong country effects and small effects of age were found. Based on ADHD-RS-IV, 88.5% of patients met the criteria for any ADHD diagnosis. Correlations between ADHD-RS-IV and measures of functional impairment were low but statistically significant. The correlations with SDQ and CHIP-CE scales confirm the convergent and divergent validity of ADHD-RS-IV.
Conclusions: Impressive evidence for the cross-cultural factorial validity, internal consistency as well as convergent and divergent validity of ADHD-RS-IV was found. ADHD can be assessed reliably and validly in routine care across Europe. The ICD-10 3-factor model seems to be less robust than the DSM-IV 2-factor model, but may be a good description for special populations (boys, younger children).
Similar articles
-
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I4-14. doi: 10.1007/s00787-006-1002-0. Eur Child Adolesc Psychiatry. 2006. PMID: 17177015
-
Psychopathological screening of children with ADHD: Strengths and Difficulties Questionnaire in a pan-European study.Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I56-62. doi: 10.1007/s00787-006-1008-7. Eur Child Adolesc Psychiatry. 2006. PMID: 17177017
-
Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.Pediatrics. 2004 Nov;114(5):e541-7. doi: 10.1542/peds.2004-0844. Pediatrics. 2004. PMID: 15520087
-
Psychopathological rating scales for diagnostic use in adults with attention-deficit/hyperactivity disorder (ADHD).Eur Arch Psychiatry Clin Neurosci. 2006 Sep;256 Suppl 1:i3-11. doi: 10.1007/s00406-006-1001-7. Eur Arch Psychiatry Clin Neurosci. 2006. PMID: 16977549 Review.
-
[Standardised psychopathological rating scales for the diagnosis of ADHD in adults].Fortschr Neurol Psychiatr. 2013 Jul;81(7):381-9. doi: 10.1055/s-0033-1335740. Epub 2013 Jul 15. Fortschr Neurol Psychiatr. 2013. PMID: 23856943 Review. German.
Cited by
-
Improved quality of life among adolescents with attention-deficit/hyperactivity disorder is mediated by protective factors: a cross sectional survey.BMC Psychiatry. 2015 May 7;15:108. doi: 10.1186/s12888-015-0491-0. BMC Psychiatry. 2015. PMID: 25948117 Free PMC article.
-
Differences between subclinical attention-deficit/hyperactivity and autistic traits in default mode, salience, and frontoparietal network connectivities in young adult Japanese.Sci Rep. 2023 Nov 13;13(1):19724. doi: 10.1038/s41598-023-47034-7. Sci Rep. 2023. PMID: 37957246 Free PMC article.
-
Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study.Eur Child Adolesc Psychiatry. 2006 Dec;15 Suppl 1:I4-14. doi: 10.1007/s00787-006-1002-0. Eur Child Adolesc Psychiatry. 2006. PMID: 17177015
-
Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial.BMC Psychiatry. 2022 Jun 2;22(1):375. doi: 10.1186/s12888-022-04019-6. BMC Psychiatry. 2022. PMID: 35655149 Free PMC article. Clinical Trial.
-
Psychometric properties of the quality of life scale Child Health and Illness Profile-Child Edition in a combined analysis of five atomoxetine trials.Atten Defic Hyperact Disord. 2011 Dec;3(4):335-49. doi: 10.1007/s12402-011-0066-y. Epub 2011 Oct 11. Atten Defic Hyperact Disord. 2011. PMID: 21986814 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous